Articles tagged with Sars Cov 2
A new study from La Jolla Institute for Immunology shows that the Moderna COVID-19 vaccine generates durable T cell memory and antibodies, even in people over 70. The researchers found strong CD4+ and CD8+ T cell responses to the vaccine, comparable to those seen in recovered COVID-19 patients.
A Michigan Medicine study found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months. Nearly 90% of participants produced spike and nucleocapsid antibody responses, and all but one had persistent antibody levels at follow-up.
Researchers analyzed genome sequences and mobile phone data to track Covid-19 spread in Bangladesh. A three-day window between lockdown announcements and enforcement led to increased infections as citizens traveled to other areas.
Researchers analyzed over 2000 SARS-CoV-2 protein structures to identify viral proteins that 'mimic' and 'hijack' human proteins. The study found three coronavirus proteins that 'mimicked' human proteins, allowing the virus to evade the immune system and contribute to variation in COVID-19 outcomes.
Researchers found that coloured and 3D images of SARS-CoV-2 increase perceived infectivity, while beauty detracts from educational value. The study highlights the role of media in distributing visually appealing yet potentially misleading information about the pandemic.
Researchers used complex computer simulations to study the attachment of SARS-CoV-2 and its variants to human cells. They found that the virus has two main locations where it grabs onto the host cell receptor ACE2, with early strains having a slippery interaction at one region that becomes less slippery as variants evolve.
A study led by Duke University researchers found that nearly 2.7 million people in the US lost employer-based health insurance during the spring and summer of 2020, but gained coverage through government programs like Medicaid. The study suggests that recent policy changes created a safety net to support those affected by job loss.
A team of researchers from the Beckman Institute for Advanced Science and Technology has developed a fast, accurate, and cost-effective COVID-19 test. Using label-free microscopic imaging combined with artificial intelligence, they can detect and classify SARS-CoV-2 in under one minute.
A study conducted by RCSI has demonstrated that a saliva PCR test is almost as accurate as the standard nose and throat swab, enabling greater capacity for frequent testing. The saliva screening represents a less invasive alternative with the potential to increase compliance with screening.
Researchers have identified nine FDA-approved drugs that can effectively suppress SARS-CoV-2 replication in human cells. These compounds have been shown to be safe in humans and could potentially provide an alternative treatment for COVID-19 patients.
A recent study found that breastfeeding mothers who received Pfizer-BioNTech or Moderna COVID-19 vaccines experienced temporary symptoms such as pain and swelling at the injection site, chills, muscle/body aches, fever, and vomiting. The study also reported no serious side effects in breastfed infants.
Scientists at CIBFar have discovered the molecular mechanism of SARS-CoV-2's main protease, which enables the virus to replicate in host cells. The study provides valuable insights into the process and has immediate applications for developing antiviral drugs.
Researchers at the University of California - San Diego have developed COVID-19 vaccine candidates made from plant viruses and bacteriophages, which can be stored and shipped without refrigeration. These vaccines trigger high production of neutralizing antibodies in mice, offering a potential solution for global distribution efforts.
The Delta variant's ability to evade neutralizing antibodies and its increased infectivity have contributed to its spread, making vaccination and infection control crucial in the post-vaccination era. The variant was found to be more efficient at replicating and spreading than other variants, giving it a selection advantage.
Researchers analyzed plasma and single immune cells from nearly 200 COVID-19 patients and found metabolic changes associated with disease severity. The study's findings could lead to better therapies targeting immune-metabolic changes in severe disease cases.
New research found that COVID-19 infection does not significantly impact lung function in young adults, including those with asthma. Lung function in children and adolescents also appears to be unimpaired after infection, apart from severe cases.
The study found SARS-CoV-2 antibodies in 44% of blood donors aged 16 to 64 in Kenya. The results suggest that the virus may have circulated in the country before widespread reporting began.
A study based on US blood donations found increasing seroprevalence of SARS-CoV-2 antibodies over time, with variations by age, race, and geographic region. Seroprevalence estimates the prevalence of SARS-CoV-2-specific antibodies due to natural infection or vaccination.
A national study shows that reducing US jail populations leads to community-wide public health benefits, as overcrowded facilities become 'infectious disease incubators' for COVID-19. Decarceration reduces the spread of SARS-CoV-2, benefiting both those released and communities nationwide.
Researchers compared antibody responses in adults receiving Pfizer/BioNTech and Moderna COVID-19 vaccines. The study found differences in antibody responses among young and older adults. Younger recipients showed higher antibody levels after vaccination.
A study of highly vaccinated health workers found that COVID-19 vaccines lost effectiveness in protecting against symptomatic infection by July, with only 65% protection remaining. The emergence of the delta variant and lifting of masking mandates contributed to this decline in vaccine efficacy.
A new diagnostic system developed by RIKEN researchers can rapidly and sensitively measure COVID-19 antibodies, enabling precise testing at medical facilities. The system uses a microchip to detect antibodies with sensitivity 500 times higher than conventional methods.
A recent study analyzed data from the Centers for Disease Control and Prevention's coronavirus self-checker to identify symptoms reported by adults with and without SARS-CoV-2 infection following a loss of taste or smell. The results revealed distinct symptom profiles for individuals with and without the virus.
The SARS-CoV-2 Lambda variant has been detected in over 30 countries worldwide, with rapid spread in Peru and low circulation in neighboring countries. The study found that the variant's infectivity is high, but its effects on clinical severity and vaccine effectiveness are poorly documented.
A novel COVID-19 vaccine candidate demonstrates high efficacy in preclinical models by stimulating the immune system and inducing a robust neutralizing antibody response. The vaccine protects against reinfection and provides better protection than natural immunity, making it a potential supplement to existing vaccines.
Research reveals a significant decline in kidney function among COVID-19 long-haulers and even those with mild infections. The study highlights the critical need for paying attention to kidney function and disease in caring for patients who have had COVID-19, as kidney problems can be silent and untreated until it's too late.
A large-scale UK study confirms that COVID-19 vaccines are effective in reducing severe illness and hospitalisation. The study found that people who received one or two vaccine doses had lower odds of severe disease or hospitalisation than unvaccinated individuals, with a significant reduction in long COVID cases.
Researchers have simulated the SARS-CoV-2 spike protein structure and found that glycans play a crucial role in cell entry. Disrupting these structures could potentially halt virus transmission. The study provides insight into potential targets for COVID-19 treatment and vaccine development.
A recent study by researchers at the University of Helsinki found that low-density granulocytes (LDG) play a significant role in weakening the immune response in covid-19 patients. The study revealed that LDGs inhibit T lymphocyte division, leading to suppressed adaptive immunity against the virus.
A new study by OHSU researchers found that blood serum from vaccinated or infected individuals shows significantly reduced defense against two widely circulating SARS-CoV-2 variants. The findings emphasize the importance of vaccinations combined with maintaining public health measures to cut off the spread of the virus.
Scientists analyzed two telecommuting strategies to slow Sars-CoV-2 spread; the 'rotating week-by-week' approach was most effective in controlling epidemics. By combining these strategies with health measures, local reproduction numbers can be effectively controlled.
Researchers at West Virginia University are monitoring wastewater statewide for COVID-19 using an egg-shaped robot that collects samples every 20 minutes. The project aims to develop a testing network throughout the state, providing early indicators of changes in community-level spread of COVID-19.
A comprehensive review finds that many respiratory viruses, including SARS-CoV-2, influenza, and measles, can spread through airborne transmission via aerosols. The study's findings suggest that indoor air quality and ventilation play a crucial role in reducing the transmission of infectious virus-laden aerosols.
A study estimates that 103 million Americans had COVID-19 by the end of 2020, accounting for 31% of the population. Undocumented cases accounted for three-quarters of infections, which were often mild or asymptomatic.
Researchers created a model to estimate viral population variability using epidemiological data, predicting the emergence of novel variants. The study suggests that lack of vaccination increases mutation frequency and spread.
A review of scientific literature found pregnant women infected by SARS-CoV-2 have a higher risk of developing pre-eclampsia due to reduced ACE2 availability. ACE2 plays a crucial role in placental development, blood pressure control, and fetal development, making its impairment more susceptible to serious complications.
Research from Virginia Tech found that women report greater fear of health risks from COVID-19, while men express more concern about economic implications. The study suggests that emphasizing both health and economic benefits can encourage people to take preventative measures.
Researchers developed a new model to study turbulent puffs, revealing the impact of temperature and humidity on turbulence. The findings suggest that buoyancy plays a significant role in shaping the behavior of tiny fluctuations within the puff, which can affect the movement of airborne droplets.
Carnivorous animals lack key genes needed to detect and respond to infection, making them asymptomatic carriers of disease-causing pathogens. This can lead to the formation of undetected disease reservoirs that can mutate and become a risk to human health.
Research from the University of Florida found that COVID-19 vaccination significantly increases antibodies against SARS-CoV-2 in breast milk, providing passive immunity to newborns. The study suggests that vaccinated mothers can help protect their babies from COVID-19 illness.
Scientists have developed stable peptide mimics called peptoids to treat viruses and prevent infections. Peptoids, such as those tested against SARS-CoV-2 and HSV-1, could one day cure or prevent many kinds of infections, including COVID-19.
Researchers have identified a potential advantage of weakened SARS-CoV-2 variants as immunogens, sparking interest in their use for live-attenuated vaccines. The variants, which emerge rapidly during cell culture propagation, show resistance to subsequent infection with both the parental strain and emerging variants.
The COVID-19 pandemic led to an increase in the proportion of community-dwelling homebound adults aged 70 or older in the US, particularly among Black non-Hispanic and Hispanic/Latino individuals. Compliance with social distancing measures is believed to be a key factor contributing to this trend.
Researchers at WashU Medicine have identified an antibody that is highly protective at low doses against a wide range of viral variants. The antibody targets a part of the virus' spike protein that differs little across variants, making it unlikely to lose potency as the virus mutates.
During the COVID-19 pandemic, U.S. alcohol retail store sales increased compared to usual trends, indicating a rise in home drinking and potential higher alcohol consumption. The study found that beer, wine, and liquor store sales increased by 17%, while food services and drinking places sales decreased markedly.
A new study by Ivan Zanoni at Boston Children's Hospital reveals a complex picture of interferon production in mild versus severe COVID-19. The researchers found that different types of interferons have opposite roles in the upper and lower respiratory tract, and that specific interferons determine disease severity.
A Rutgers study found that people with severe or prolonged COVID-19 have higher antibody levels against the virus. The study of 831 participants showed that immune responses vary by symptom severity, with those having persistent symptoms producing more antibodies.
Scientists have discovered a hidden 'gate' in the SARS-CoV-2 spike protein that allows the virus to infect cells. The discovery reveals a glycan mechanism that opens the gate, enabling the virus to enter host cells. This breakthrough could lead to new therapeutics to counter COVID infection.
A new study found that vaccinated SARS survivors can produce antibodies capable of neutralizing not only current but also future coronavirus threats. The breakthrough could lead to the development of an effective, broad-spectrum vaccine against different coronaviruses.
Researchers studied electrical conduction through membranes during Controlled Breakdown, a technique to fabricate single nanopores. They found that redox reactions occur at the membrane-electrolyte interface, allowing localization of pore formation using metal microelectrodes.
A new approach has identified T cells in Covid-19 patients, revealing their appearance, number, and activity level against SARS-CoV-2. The study distinguishes between active and dormant T cells, enabling a better understanding of the immune response to the virus.
A new study by University of Waterloo researchers highlights the importance of using better face masks and proper ventilation to mitigate COVID-19 transmission indoors. The study found that higher-quality masks can filter up to 50% of exhaled aerosol droplets, while even modest ventilation rates are effective in reducing risk.
A NIH study published in The New England Journal of Medicine found that administering convalescent plasma to outpatients with early symptoms of COVID-19 did not prevent disease progression. The trial, which enrolled over 500 participants, showed a significant reduction of less than 2% in disease progression.
The SARS-CoV-2 Delta variant has rapidly spread across the globe, infecting over 130 countries. It has higher transmissibility than ancestral strains, posing a risk to unvaccinated populations. Currently authorized vaccines remain effective against symptomatic infections and hospitalizations due to the Delta variant.
A multidisciplinary team reveals two structural points in the Spike protein of SARS-CoV-2 that allow the virus to deceive the immune system. These mutations can be detected and inform strategies to control the pandemic.
The NIH study reveals that aerosol exposure directly deposits SARS-CoV-2 deep into the lungs, while fomite exposure leads to initial virus replication in the nose. The findings support public health guidance focused on masking, air filtration, social distancing, and handwashing.
Researchers at Washington University School of Medicine found that COVID-19 vaccination antibodies are effective against the delta variant. The study analyzed antibodies generated by people in response to the Pfizer vaccine and found that 12 out of 13 antibodies recognized both alpha and delta variants, while one antibody failed to rec...
Researchers at UNC Chapel Hill found that first-year college students reported decreased alcohol use and binge drinking during the pandemic. Social factors such as social distancing and reduced social support were associated with these decreases, while stress-related factors played a lesser role for most students.
Researchers at the National Eye Institute developed a new sample preparation method to detect SARS-Cov-2, simplifying purification and potentially reducing test time and cost. The method uses a chelating agent to preserve RNA in samples, allowing for direct detection and increasing sensitivity.
A study found that mRNA vaccine recipients with prior SARS-CoV-2 infection experienced more severe symptoms after vaccination. The study suggests vaccine type may influence symptom severity in individuals with a history of COVID-19 infection.